SpectraScience WavSTAT Optical Biopsy System to Be Featured at United European Gastroenterology Week

SpectraScience Initiates Sales Training With PENTAX in Germany and Belgium

SAN DIEGO, CA--(Marketwire - Sep 27, 2012) - SpectraScience, Inc. ( OTCQB : SCIE ), a San Diego-based medical device company, recently completed training of the PENTAX Europe sales teams in Germany and Belgium on the...

SpectraScience to Present at the Rodman & Renshaw Global Investment Conference on September 11th

SAN DIEGO, CA--(Marketwire -09/06/12)- SpectraScience, Inc. (SCIE), a San Diego based medical device company, today announced that Chief Executive Officer Michael Oliver will be presenting at the Rodman & Renshaw Annual...

SpectraScience Completes Initial WavSTAT4 Installation and Training With PENTAX Europe

SAN DIEGO, CA--(Marketwire -09/05/12)- SpectraScience, Inc. (SCIE), a San Diego-based medical device company, today announced it has successfully completed installation and training for the WavSTAT4 Optical Biopsy System...

SpectraScience Reports Estimated Second Quarter Revenue of $310,000

Conference Call to be held at 4:30 p.m. Eastern Today

SAN DIEGO, July 9, 2012 (MARKETWIRE) – SpectraScience, Inc. (OTCQB: SCIE), a San Diego-based medical device company, today announced that it expects revenue of...

SpectraScience to Present at the OneMed Forum on July 12th

SAN DIEGO, July 6, 2012 (MARKETWIRE) – SpectraScience, Inc. (OTCQB:SCIE), a San Diego based medical device company, today announced that Chief Executive Officer Michael Oliver will be presenting at the OneMed Forum...

SpectraScience to Hold Business Update Conference Call on July 9th

SAN DIEGO, July 3, 2012 (MARKETWIRE) – SpectraScience, Inc. (OTCPK: SCIE), a San Diego based medical device company, today announced thatit will hold a conference call on Monday, July 9, 2012 at 4:30 p.m. Eastern (1:30...

SpectraScience Begins Shipments of WavSTAT4 Optical Biopsy System to PENTAX in Europe

SAN DIEGO, June 29, 2012 (MARKETWIRE) – SpectraScience, Inc. (OTCQB: SCIE), a San Diego-based medical device company, has begun initial shipments of its WavSTAT4 Optical Biopsy System to PENTAX Europe GmbH under the...

SpectraScience Signs Europe and Middle East Distribution Agreement with PENTAX for the WavSTAT OBS

SAN DIEGO, June 18, 2012 (MARKETWIRE) – SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, has signed an exclusive five-year agreement with PENTAX Europe GmbH to distribute its WavSTAT Optical...

SpectraScience’s WavSTAT OBS Highlighted in Presentations at Digestive Disease Week

Research data shows effectiveness in diagnosing esophageal and colorectal cancer

SAN DIEGO, May 24, 2012 (MARKETWIRE) – Presentations at the recently concluded Digestive Disease Week Conference (DDW) in San Diego...

SpectraScience to Exhibit WavSTAT4 Optical Biopsy System at Digestive Disease Week Conference

May 19-22 in San Diego - Academic research presentations to include data from clinical studies using WavSTAT to diagnose colorectal and esophageal cancer

SAN DIEGO, May 18, 2012 (MARKETWIRE) – SpectraScience, Inc....

Interview With The President and CEO: SpectraScience, Inc. (SCIE) - Michael P. Oliver

67 WALL STREET, New York - March 19, 2012 - The Wall Street Transcript has just published its Medical Devices Report offering a timely review of the sector to serious investors and industry executives. This special page...

SpectraScience to Hold Business Update Conference Call on March 27, 2012

SAN DIEGO, CA -- SpectraScience, Inc. (OTCQB:SCIE.QB), a San Diego-based medical device company, today announced that it will hold a conference call on Tuesday, March 27, 2012 at Noon Eastern (9:00 a.m. Pacific) to provide...

SpectraScience to Present at the LHA Life Sciences & Medtech Virtual Conference on February 16, 2012

SAN DIEGO, CA -- SpectraScience, Inc.(OTCQB:SCIE.QB, a San Diego based medical device company, today announced that Chief Executive Officer Michael Oliver will present to investors as part of the LHA Life Sciences &...

SpectraScience Names Hughes Wielemans as Director of Business Development in Europe

SAN DIEGO, CA - SpectraScience, Inc.(OTCQB:SCIE.QB, a San Diego based medical device company, today announced it has named Hughes Wielemans as Director of Business Development, Europe, effective February 1.

Mr. Wielemans...

SpectraScience to Present at OneMedForum on January 11, 2012

SAN DIEGO, CA--(Marketwire -01/09/12)- SpectraScience, Inc.(OTCQB: SCIE.QB), a San Diego based medical device company, today announced that President and Chief Executive Officer Michael Oliver will present to investors and...

SpectraScience Begins Shipments of WavSTAT4 Optical Biopsy System to European Customers

SAN DIEGO, CA - SpectraScience, Inc.(OTCQB:SCIE.OB), a San Diego based medical device company, today announced that it had begun initial sales and shipments of the new WavSTAT4 Optical Biopsy System® to customers in Europe...

SpectraScience to Present at the 4th Annual LD Micro Conference on December 7, 2011

San Diego, California -- SpectraScience, Inc. (OYCQB:SCIE), a San Diego based medical device company, today announced that Chief Executive Officer Michael Oliver will be presenting at the annual LD MICRO Growth Conference...

SpectraScience to Hold Business Update Conference Call on November 10, 2011

SAN DIEGO, November 3, 2011 (MARKETWIRE) – SpectraScience, Inc. (OTCQB:SCIE), a San Diego based medical device company, today announced that it will hold a conference call on Thursday, November 10, 2011 at 4:30 p.m....

SpectraScience to Introduce WavSTAT4 Optical Biopsy System at United European Gastroenterology Week

SAN DIEGO, October 6, 2011 (MARKETWIRE) - SpectraScience, Inc. (OTCQB:SCIE), a San Diego based medical device company, today announced that the Company will introduce for sale in Europe its redesigned WavSTAT4 Optical...

SpectraScience Strengthens Intellectual Property Portfolio

SAN DIEGO, September 8, 2011 (MARKETWIRE) - SpectraScience, Inc. (OTCQB:SCIE), a San Diego based medical device company, today announced it was recently granted a new tissue- analysis patent, further strengthening its...